Print This Page
Share this page: More
 

Trevena Heart Failure Study

Summary of Trial: A randomized, double-blind, placebo-controlled, adaptive, ascending dose-titration study to evaluate the safety, tolerability, pharmacokinetics, and invasive hemodynamics of TRV120027 in patients with stable  heart failure.

PI: Dr. Stuart Russell

If interested, please call 410-955-5708 or email Dr. Russell at srusse14@jhmi.edu.

 

HVI Employees: Manage Clinical Trials

Do you need to add, update or delete a clinical trial for the Heart and Vascular Institute website? Use this form.

Ranked #1 by US News & World Report

US News and World Report Best HospitalsJohns Hopkins Hospital has earned the top spot in US News News & World Report's annual rankings of American hospitals — for the 21st year in a row.

This year, the Heart and Vascular Institute ranked #3 nationally for the Heart & Heart Surgery program.

Make a Gift to the Heart and Vascular Institute

Out-of-State and International Patients - Find Out More

Trainings and Fellowships

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

Privacy Policy and Disclaimer